Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1275 of 3284 entries
View as:

Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).

Phase: N/A Priority: Normal
NCT ID: NCT03164616 Org: User:
Start: 06/01/17 End: 11/15/27 Due: 11/15/28

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD

Phase: N/A Priority: Normal
NCT ID: NCT06883305 Org: User:
Start: 03/18/25 End: 06/05/29 Due: 06/05/30

The Anifrolumab PRIM Program

Phase: N/A Priority: Normal
NCT ID: NCT06795893 Org: User:
Start: 09/30/25 End: 04/15/31 Due: 04/15/32

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05417594 Org: User:
Start: 06/24/22 End: 02/19/27 Due: 02/19/28

A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated Eosinophils

Phase: N/A Priority: Normal
NCT ID: NCT06897748 Org: User:
Start: 04/12/25 End: 04/30/26 Due: 04/30/27

Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression

Phase: N/A Priority: Normal
NCT ID: NCT01256177 Org: User:
Start: 12/31/10 End: 11/30/12 Due: 11/30/13

Clinical Study Assessing the Safety, Tolerability, and Pharmacokinetics of Intravenous AZD5099 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01340183 Org: User:
Start: 05/31/11 End: 12/31/11 Due: 12/31/12

First in Human Study of AZD9592 in Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05647122 Org: User:
Start: 12/22/22 End: 01/22/26 Due: 01/22/27

Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06750289 Org: User:
Start: 03/28/25 End: 11/02/27 Due: 11/02/28

Multicenter, Observational, Descriptive Study of the Diagnosis, Course and Treatment of Patients With SLE in Routine Practice in Kazakhstan: a Registry Study With Retrospective and Prospective Components.

Phase: N/A Priority: Normal
NCT ID: NCT06899633 Org: User:
Start: 05/15/25 End: 11/03/25 Due: 11/03/26

A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z

Phase: N/A Priority: Normal
NCT ID: NCT06929260 Org: User:
Start: 05/21/25 End: 03/02/26 Due: 03/02/27

A Study to Compare the Efficacy and Safety of 2 Dosing Regimens of IV Infusions of AZD9773 (CytoFab™) With Placebo in Adult Patients With Severe Sepsis and/or Septic Shock

Phase: N/A Priority: Normal
NCT ID: NCT01145560 Org: User:
Start: 10/31/10 End: 05/31/12 Due: 05/31/13

Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia

Phase: N/A Priority: Normal
NCT ID: NCT02078219 Org: User:
Start: 01/05/14 End: 03/13/15 Due: 03/13/16

Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01348737 Org: User:
Start: 06/30/11 End: 11/30/11 Due: 11/30/12

A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants

Phase: N/A Priority: Normal
NCT ID: NCT06942936 Org: User:
Start: 05/28/25 End: 12/11/25 Due: 12/11/26

Development of AECOPD Identification Tool (DETECT Study)

Phase: N/A Priority: Normal
NCT ID: NCT03556475 Org: User:
Start: 04/28/20 End: 01/18/21 Due: 01/18/22

Iressa v BSC (Best Supportive Care) in First Line NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00259064 Org: User:
Start: 09/30/04 End: 04/30/16 Due: 04/30/17

Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00758459 Org: User:
Start: 09/30/08 End: 03/31/09 Due: 03/31/10

LTFU for All Cell and Gene Therapy Studies

Phase: N/A Priority: Normal
NCT ID: NCT06194461 Org: User:
Start: 09/17/25 End: 11/29/41 Due: 11/29/42

The Impact of PCCM on Healthcare Among Asthma or Chronic Obstructive Pulmonary Disease (COPD) or Asthma-COPD Overlap Patients

Phase: N/A Priority: Normal
NCT ID: NCT04905420 Org: User:
Start: 12/08/21 End: 06/12/23 Due: 06/12/24

Evaluation of Diabetes Care at Austrian GPs

Phase: N/A Priority: Normal
NCT ID: NCT00979394 Org: User:
Start: 10/31/09 End: 01/31/10 Due: 01/31/11

Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02272790 Org: User:
Start: 01/30/15 End: 03/08/23 Due: 03/08/24

Open Label Phase 1 Study in Japan for Patient With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01353781 Org: User:
Start: 06/30/11 End: 07/31/14 Due: 07/31/15

Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00509028 Org: User:
Start: 12/31/06 End: 10/31/08 Due: 10/31/09

ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02910089 Org: User:
Start: 10/20/16 End: 12/20/17 Due: 12/20/18